The Use of Metronidazole in the Treatment of Alcoholism: A Pilot Study
Abstract
In summary we can note that metronidazole in divided doses of from 500 to 750 mg. daily appears to consistently produce a marked aversion toward the ingestion of alcohol within two weeks in those well motivated in their desire to stop drinking. It is nontoxic and has a wide margin of safety. Hence, it holds forth great promise.
Further clinical studies are in order to appraise and delineate its value in the problem of alcoholism. We plan to continue and extend the present studies, utilizing a comparison group of alcoholics treated by means other than metronidazole.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
